Lucy Y. Lei
Research Subjects
Lucy Y. Lei has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Satish R. Raj
Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
5 shared publications - Robert Stanley Sheldon
Department of Cardiac Sciences, Libin Cardiovascular Institute University of Calgary Calgary Alberta Canada
4 shared publications - Derek S. Chew
Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
2 shared publications Aaron A. Phillips
Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine (N.A.S., A.A.P., S.R., M.L., K.K., K.M.B., J.G.J., L.Y.L., R.S.S., D.V.E., S.R.R.), University of Calgary, AB, Canada
1 shared publication- Aaron Johnston
Distributed Learning and Rural Initiatives, University of Calgary
1 shared publication Aidan Cornhill
Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta (Y.P., L.Y.L., S.D., Y.M., A.C., A.S., J.F., S.R., R.S., M.S., C.P.L., A.G.H., B.H., N.M., M.B., N.F., J.A.W.), Cumming School of Medicine, University of Calgary, Canada
1 shared publication
Latest Publications
- Open Access
- 29 July 2025
- Published by University Library System, University of Pittsburgh in International Journal of Medical Students
- Vol. 13 (3) , 244-254
Awareness and Perspectives on the Role of Artificial Intelligence in Primary Care: A cross-Sectional Survey of Rural and Urban Primary Care Physicians in Alberta, Canada
Background: Artificial intelligence (AI) is increasingly integrated into healthcare, yet physicians’ awareness and perspectives remain underexplored. While often associated with imaging, AI applications also include online scheduling, digitized records, virtual consultations, and drug dosage algorithms. This study surveyed Canadian primary care physicians (PCPs) to assess their awareness and attitudes toward AI in healthcare. Methods: A cross-sectional survey was distributed via email and newsletters to family physicians across Alberta, including both urban and rural settings. Responses were collected through Qualtrics. Results: Of 79 responses, 46 met inclusion criteria. Most respondents practiced in urban areas (63%) and had no prior AI training (65%). Rural physicians reported greater comfort and interest in AI, including its use for monitoring treatment adherence (p=0.043) and analyzing EMR data for health management (p=0.027). Knowledge of AI varied widely: only 30% recognized that deep learning involves artificial neural networks, while 44% reported no knowledge of the concept. Commonly used AI tools included ECG interpreters (65%) and language translators (37%). Physicians showed interest in expanded medical uses of AI. Conclusion: There is a lack of knowledge and use of AI tools in medicine, with both urban and rural physicians’ responses suggesting a need for more education and training in AI. The “Lack of human connection” was the main fear that was expressed regarding the use of AI in healthcare suggesting concerns about potential impacts on patient-provider relationships. This survey's findings may inform future research into the development and implementation of AI in primary care.
- 29 July 2025
- Published by University Library System, University of Pittsburgh in International Journal of Medical Students
- Vol. 13 (3) , 244-254
Open AccessAwareness and Perspectives on the Role of Artificial Intelligence in Primary Care: A cross-Sectional Survey of Rural and Urban Primary Care Physicians in Alberta, Canada
Background: Artificial intelligence (AI) is increasingly integrated into healthcare, yet physicians’ awareness and perspectives remain underexplored. While often associated with imaging, AI applications also include online scheduling, digitized records, virtual consultations, and drug dosage algorithms. This study surveyed Canadian primary care physicians (PCPs) to assess their awareness and attitudes toward AI in healthcare. Methods: A cross-sectional survey was distributed via email and newsletters to family physicians across Alberta, including both urban and rural settings. Responses were collected through Qualtrics. Results: Of 79 responses, 46 met inclusion criteria. Most respondents practiced in urban areas (63%) and had no prior AI training (65%). Rural physicians reported greater comfort and interest in AI, including its use for monitoring treatment adherence (p=0.043) and analyzing EMR data for health management (p=0.027). Knowledge of AI varied widely: only 30% recognized that deep learning involves artificial neural networks, while 44% reported no knowledge of the concept. Commonly used AI tools included ECG interpreters (65%) and language translators (37%). Physicians showed interest in expanded medical uses of AI. Conclusion: There is a lack of knowledge and use of AI tools in medicine, with both urban and rural physicians’ responses suggesting a need for more education and training in AI. The “Lack of human connection” was the main fear that was expressed regarding the use of AI in healthcare suggesting concerns about potential impacts on patient-provider relationships. This survey's findings may inform future research into the development and implementation of AI in primary care.
- Open Access
- 16 June 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (7)
Cost-effectiveness of an intraoperative antibacterial envelope in preventing cardiac implantable device-associated infections: a systematic review
Aims: Intraoperative use of an antibacterial envelope during surgery for cardiac implantable electronic device (CIED) surgery reduces infection risk at increased procedural costs. The objective of this systematic review was to synthesize the published economic literature on the cost-effectiveness of the antibacterial envelope. Methods and results: A systematic review of the published literature was conducted to identify economic evaluations (i.e. cost-utility, cost-effectiveness, and cost-benefit studies) comparing the antibacterial envelope compared with standard of care in preventing post-operative CIED infection. Systematic review best practices were followed, and study quality was assessed. Of 142 unique citations, 7 studies met the inclusion criteria for qualitative synthesis. All cost-effectiveness studies were conducted from the healthcare payer perspective of high-income countries. The base case analysis of most economic studies (5/7) reported a cost per quality-adjusted life year gained that exceeded country-specific societal thresholds for good value in healthcare. Cost-effectiveness was highly dependent on the baseline infection risk. That is, at current pricing, the antibacterial envelope may be cost-effective at base infection rates of greater than 3%, and cost-savings at infection rates that exceed 6%. Conclusion: Routine use of an antibacterial envelope in patients undergoing CIED procedures (implantation or revision) is unlikely to be cost-effective except among those at high risk for post-operative infection. Individualized risk assessment may help guide efficient and value-based use of this technology.
- 16 June 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (7)
Open AccessCost-effectiveness of an intraoperative antibacterial envelope in preventing cardiac implantable device-associated infections: a systematic review
Aims: Intraoperative use of an antibacterial envelope during surgery for cardiac implantable electronic device (CIED) surgery reduces infection risk at increased procedural costs. The objective of this systematic review was to synthesize the published economic literature on the cost-effectiveness of the antibacterial envelope. Methods and results: A systematic review of the published literature was conducted to identify economic evaluations (i.e. cost-utility, cost-effectiveness, and cost-benefit studies) comparing the antibacterial envelope compared with standard of care in preventing post-operative CIED infection. Systematic review best practices were followed, and study quality was assessed. Of 142 unique citations, 7 studies met the inclusion criteria for qualitative synthesis. All cost-effectiveness studies were conducted from the healthcare payer perspective of high-income countries. The base case analysis of most economic studies (5/7) reported a cost per quality-adjusted life year gained that exceeded country-specific societal thresholds for good value in healthcare. Cost-effectiveness was highly dependent on the baseline infection risk. That is, at current pricing, the antibacterial envelope may be cost-effective at base infection rates of greater than 3%, and cost-savings at infection rates that exceed 6%. Conclusion: Routine use of an antibacterial envelope in patients undergoing CIED procedures (implantation or revision) is unlikely to be cost-effective except among those at high risk for post-operative infection. Individualized risk assessment may help guide efficient and value-based use of this technology.
- Open Access
- 7 November 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (21) , e029645
Hemodynamic Effects of the Osmopressor Response: A Systematic Review and Meta‐Analysis
Background: Rapidly consuming water may offer practical orthostatic hypotension therapy. However, its efficacy across disorders remains uncertain. This study aims to assess the impact of rapid 350‐ to 500‐mL water intake on systolic and diastolic blood pressure (BP) and heart rate (HR) through a systematic review and meta‐analysis. Methods and Results: We systematically reviewed MEDLINE and Embase up to June 2023, including randomized controlled trials and prospective cohort studies. Using random‐effects meta‐analysis, we calculated pooled mean differences (MDs) for maximum hemodynamic effects of rapid 350‐ to 500‐mL water bolus consumption. Participants with orthostatic hypotension experienced increased systolic BP (MD, 24.18 [95% CI, 15.48–32.88]) and diastolic BP (MD, 11.98 [95% CI, 8.87–15.09]) with decreased HR (MD, −3.46 [95% CI, −5.21 to −1.71]). Similar results were observed in multiple system atrophy and pure autonomic failure subgroup analysis. Healthy participants showed modest increases in systolic BP (MD, 2.33 [95% CI, 1.02–3.64]) and diastolic BP (MD, 2.73 [95% CI, 1.15–4.30]), but HR changes were not significant (MD, −2.06 [95% CI, −5.25 to 1.13]). Water had no significant hemodynamic effects in patients with seated or supine postural tachycardia syndrome, although standing effects were unassessed. Our data do not exclude water's potential standing effect in postural tachycardia syndrome. Conclusions: In patients with orthostatic hypotension, rapid water intake elevated short‐term systolic BP and diastolic BP, with mild HR reduction when seated or supine. Healthy participants exhibited similar but milder effects. However, patients with postural tachycardia syndrome did not experience these changes in seated or supine positions. Further research is needed to evaluate the promising impact of rapid water ingestion on patients with postural tachycardia syndrome in a standing position, which was not addressed in our study.
- 7 November 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (21) , e029645
Open AccessHemodynamic Effects of the Osmopressor Response: A Systematic Review and Meta‐Analysis
Background: Rapidly consuming water may offer practical orthostatic hypotension therapy. However, its efficacy across disorders remains uncertain. This study aims to assess the impact of rapid 350‐ to 500‐mL water intake on systolic and diastolic blood pressure (BP) and heart rate (HR) through a systematic review and meta‐analysis. Methods and Results: We systematically reviewed MEDLINE and Embase up to June 2023, including randomized controlled trials and prospective cohort studies. Using random‐effects meta‐analysis, we calculated pooled mean differences (MDs) for maximum hemodynamic effects of rapid 350‐ to 500‐mL water bolus consumption. Participants with orthostatic hypotension experienced increased systolic BP (MD, 24.18 [95% CI, 15.48–32.88]) and diastolic BP (MD, 11.98 [95% CI, 8.87–15.09]) with decreased HR (MD, −3.46 [95% CI, −5.21 to −1.71]). Similar results were observed in multiple system atrophy and pure autonomic failure subgroup analysis. Healthy participants showed modest increases in systolic BP (MD, 2.33 [95% CI, 1.02–3.64]) and diastolic BP (MD, 2.73 [95% CI, 1.15–4.30]), but HR changes were not significant (MD, −2.06 [95% CI, −5.25 to 1.13]). Water had no significant hemodynamic effects in patients with seated or supine postural tachycardia syndrome, although standing effects were unassessed. Our data do not exclude water's potential standing effect in postural tachycardia syndrome. Conclusions: In patients with orthostatic hypotension, rapid water intake elevated short‐term systolic BP and diastolic BP, with mild HR reduction when seated or supine. Healthy participants exhibited similar but milder effects. However, patients with postural tachycardia syndrome did not experience these changes in seated or supine positions. Further research is needed to evaluate the promising impact of rapid water ingestion on patients with postural tachycardia syndrome in a standing position, which was not addressed in our study.
- Open Access
- 13 January 2022
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 24 (7) , 1171-1178
Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis
Vasovagal syncope (VVS) is a common clinical condition that lacks effective medical therapies despite being associated with significant morbidity. Current guidelines suggest that midodrine, a prodrug for an α1-adrenergic receptor agonist, might suppress VVS but supporting studies have utilized heterogeneous methods and yielded inconsistent results. To evaluate the efficacy of midodrine to prevent syncope in patients with recurrent VVS by conducting a systematic review and meta-analysis of published studies. Relevant randomized controlled trials were identified from the MEDLINE, Embase, CENTRAL, and CINAHL databases without language restriction from inception to June 2021. All studies were conducted in clinical syncope populations and compared the benefit of midodrine vs. placebo or non-pharmacological standard care. Weighted relative risks (RRs) were estimated using random effects meta-analysis techniques. Seven studies (n = 315) met inclusion criteria. Patients were 33 ± 17 years of age and 31% male. Midodrine was found to substantially reduce the likelihood of positive head-up-tilt (HUT) test outcomes [RR = 0.37 (0.23–0.59), P < 0.001]. In contrast, the pooled results of single- and double-blind clinical trials (I2 = 54%) suggested a more modest benefit from midodrine for the prevention of clinical syncope [RR = 0.51 (0.33–0.79), P = 0.003]. The two rigorous double-blind, randomized, placebo-controlled clinical trials included 179 VVS patients with minimal between-study heterogeneity (I2 = 0%) and reported a risk reduction with midodrine [RR = 0.71 (0.53–0.95), P = 0.02]. Midodrine is effective in preventing syncope induced by HUT testing and less, but still significant, RR reduction in randomized, double-blinded clinical trials.
- 13 January 2022
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 24 (7) , 1171-1178
Open AccessMidodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis
Vasovagal syncope (VVS) is a common clinical condition that lacks effective medical therapies despite being associated with significant morbidity. Current guidelines suggest that midodrine, a prodrug for an α1-adrenergic receptor agonist, might suppress VVS but supporting studies have utilized heterogeneous methods and yielded inconsistent results. To evaluate the efficacy of midodrine to prevent syncope in patients with recurrent VVS by conducting a systematic review and meta-analysis of published studies. Relevant randomized controlled trials were identified from the MEDLINE, Embase, CENTRAL, and CINAHL databases without language restriction from inception to June 2021. All studies were conducted in clinical syncope populations and compared the benefit of midodrine vs. placebo or non-pharmacological standard care. Weighted relative risks (RRs) were estimated using random effects meta-analysis techniques. Seven studies (n = 315) met inclusion criteria. Patients were 33 ± 17 years of age and 31% male. Midodrine was found to substantially reduce the likelihood of positive head-up-tilt (HUT) test outcomes [RR = 0.37 (0.23–0.59), P < 0.001]. In contrast, the pooled results of single- and double-blind clinical trials (I2 = 54%) suggested a more modest benefit from midodrine for the prevention of clinical syncope [RR = 0.51 (0.33–0.79), P = 0.003]. The two rigorous double-blind, randomized, placebo-controlled clinical trials included 179 VVS patients with minimal between-study heterogeneity (I2 = 0%) and reported a risk reduction with midodrine [RR = 0.71 (0.53–0.95), P = 0.02]. Midodrine is effective in preventing syncope induced by HUT testing and less, but still significant, RR reduction in randomized, double-blinded clinical trials.
- 6 January 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (3) , 638-647
Mitigating Initial Orthostatic Hypotension: Mechanistic Roles of Muscle Contraction Versus Sympathetic Activation
Background: Initial orthostatic hypotension (IOH) is defined by a large drop in blood pressure (BP) within 15 s of standing. IOH often presents during an active stand, but not with a passive tilt, suggesting that a muscle activation reflex involving lower body muscles plays an important role. To our knowledge, there is no literature exploring how sympathetic activation affects IOH. We hypothesized involuntary muscle contractions before standing would significantly reduce the drop in BP seen in IOH while increasing sympathetic activity would not. Methods: Study participants performed 4 sit-to-stand maneuvers including a mental stress test (serial 7 mental arithmetic stress test), cold pressor test, electrical stimulation, and no intervention. Continuous heart rate and beat-to-beat BP were measured. Cardiac output and systemic vascular resistance were estimated from these waveforms. Data are presented as mean±SD. Results: A total of 23 female IOH participants (31±8 years) completed the study. The drops in systolic BP following the serial 7 mental arithmetic stress test (−26±12 mm Hg; P =0.004), cold pressor test (−20±15 mm Hg; P P =0.01) were significantly reduced compared with no intervention (−34±11 mm Hg). The drops in systemic vascular resistance following the serial 7 mental arithmetic stress test (−391±206 dyne×s/cm 5 ; P =0.006) and cold pressor test (−386±179 dyne×s/cm 5 ; P =0.011) were significantly reduced compared with no intervention (−488±173 dyne×s/cm 5 ). Cardiac output was significantly increased upon standing (7±2 L/min) compared with during the sit (6±1 L/min; P <0.001) for electrical stimulation. Conclusion: Sympathetic activation mitigates the BP response in IOH, while involuntary muscle contraction mitigates the BP response and reduces symptoms. Active muscle contractions may induce both of these mechanisms of action in their pretreatment of IOH. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03970551.
- 6 January 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (3) , 638-647
Mitigating Initial Orthostatic Hypotension: Mechanistic Roles of Muscle Contraction Versus Sympathetic Activation
Background: Initial orthostatic hypotension (IOH) is defined by a large drop in blood pressure (BP) within 15 s of standing. IOH often presents during an active stand, but not with a passive tilt, suggesting that a muscle activation reflex involving lower body muscles plays an important role. To our knowledge, there is no literature exploring how sympathetic activation affects IOH. We hypothesized involuntary muscle contractions before standing would significantly reduce the drop in BP seen in IOH while increasing sympathetic activity would not. Methods: Study participants performed 4 sit-to-stand maneuvers including a mental stress test (serial 7 mental arithmetic stress test), cold pressor test, electrical stimulation, and no intervention. Continuous heart rate and beat-to-beat BP were measured. Cardiac output and systemic vascular resistance were estimated from these waveforms. Data are presented as mean±SD. Results: A total of 23 female IOH participants (31±8 years) completed the study. The drops in systolic BP following the serial 7 mental arithmetic stress test (−26±12 mm Hg; P =0.004), cold pressor test (−20±15 mm Hg; P P =0.01) were significantly reduced compared with no intervention (−34±11 mm Hg). The drops in systemic vascular resistance following the serial 7 mental arithmetic stress test (−391±206 dyne×s/cm 5 ; P =0.006) and cold pressor test (−386±179 dyne×s/cm 5 ; P =0.011) were significantly reduced compared with no intervention (−488±173 dyne×s/cm 5 ). Cardiac output was significantly increased upon standing (7±2 L/min) compared with during the sit (6±1 L/min; P <0.001) for electrical stimulation. Conclusion: Sympathetic activation mitigates the BP response in IOH, while involuntary muscle contraction mitigates the BP response and reduces symptoms. Active muscle contractions may induce both of these mechanisms of action in their pretreatment of IOH. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03970551.
- 22 November 2021
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 14 (12) , 1099-1101
Pharmacological Cardioversion of Atrial Tachyarrhythmias Using Single High-Dose Oral Amiodarone: A Systematic Review and Meta-Analysis
- 22 November 2021
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 14 (12) , 1099-1101
Pharmacological Cardioversion of Atrial Tachyarrhythmias Using Single High-Dose Oral Amiodarone: A Systematic Review and Meta-Analysis
- 1 March 2021
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 14 (3) , 224-235
Right Ventricular Ejection Fraction for the Prediction of Major Adverse Cardiovascular and Heart Failure-Related Events
Background: There is increasing evidence that right ventricular ejection fraction (RVEF) may provide incremental value to left ventricular (LV) ejection fraction for the prediction of major adverse cardiovascular events. To date, generalizable utility for RVEF quantification in patients with cardiovascular disease has not been established. Using a large prospective clinical outcomes registry, we investigated the prognostic value of RVEF for the prediction of major adverse cardiovascular events- and heart failure-related outcomes. Methods: Seven thousand one hundred thirty-one consecutive patients with known or suspected cardiovascular disease undergoing cardiovascular magnetic resonance imaging were prospectively enrolled. Multichamber volumetric quantification was performed by standardized operational procedures. Patients were followed for the primary composite outcome of all-cause death, survived cardiac arrest, admission for heart failure, need for transplantation or LV assist device, acute coronary syndrome, need for revascularization, stroke, or transient ischemic attack. A secondary, heart failure focused outcome of heart failure admission, need for transplantation/LV assist device or death was also studied. Results: Mean age was 54±15 years. The mean LV ejection fraction was 55±14% (range 6%–90%) with a mean RVEF of 54±10% (range 9%–87%). At a median follow-up of 908 days, 870 (12%) patients experienced the primary composite outcome and 524 (7%) the secondary outcome. Each 10% drop in RVEF was associated with a 1.3-fold increased risk of the primary outcome ( P P P <0.001) with a 1-year cumulative event rate of 22% versus 7% above this cutoff. Conclusions: RVEF is a powerful and independent predictor of major adverse cardiac events with broad generalizability across patients with known or suspected cardiovascular disease. These findings support migration towards biventricular phenotyping for the classification of risk in clinical practice. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04367220.
- 1 March 2021
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 14 (3) , 224-235
Right Ventricular Ejection Fraction for the Prediction of Major Adverse Cardiovascular and Heart Failure-Related Events
Background: There is increasing evidence that right ventricular ejection fraction (RVEF) may provide incremental value to left ventricular (LV) ejection fraction for the prediction of major adverse cardiovascular events. To date, generalizable utility for RVEF quantification in patients with cardiovascular disease has not been established. Using a large prospective clinical outcomes registry, we investigated the prognostic value of RVEF for the prediction of major adverse cardiovascular events- and heart failure-related outcomes. Methods: Seven thousand one hundred thirty-one consecutive patients with known or suspected cardiovascular disease undergoing cardiovascular magnetic resonance imaging were prospectively enrolled. Multichamber volumetric quantification was performed by standardized operational procedures. Patients were followed for the primary composite outcome of all-cause death, survived cardiac arrest, admission for heart failure, need for transplantation or LV assist device, acute coronary syndrome, need for revascularization, stroke, or transient ischemic attack. A secondary, heart failure focused outcome of heart failure admission, need for transplantation/LV assist device or death was also studied. Results: Mean age was 54±15 years. The mean LV ejection fraction was 55±14% (range 6%–90%) with a mean RVEF of 54±10% (range 9%–87%). At a median follow-up of 908 days, 870 (12%) patients experienced the primary composite outcome and 524 (7%) the secondary outcome. Each 10% drop in RVEF was associated with a 1.3-fold increased risk of the primary outcome ( P P P <0.001) with a 1-year cumulative event rate of 22% versus 7% above this cutoff. Conclusions: RVEF is a powerful and independent predictor of major adverse cardiac events with broad generalizability across patients with known or suspected cardiovascular disease. These findings support migration towards biventricular phenotyping for the classification of risk in clinical practice. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04367220.